From January 24 to 27, Guangzhou Pluslife Biotech will present its rapid molecular diagnostic system and newly innovative products, the Pluslife Mini Dock, as exhibitor in the 2022 Arab Health, which will be held in the Dubai World Trade Centre.

The Pluslife Mini Dock is an Integrated Nucleic Acid Testing Device based on the self-developed isothermal molecular detection technology. The Mini Dock can be used in comprehensive applications such as human respiratory infections including disease and pathogens like Covid-19, RTI’s, STI’s, and veterinary disease inspections. The Mini Dock aims to expanding molecular detection to clinics and individuals' family-care uses by providing quick and accurate detection results in a portable and comprehensive way.

Comparing to antigen test which detects specific proteins on the surface of the virus, the Pluslife Mini Dock detects the presence of viral genetic material even at low levels and at different stages of an active infection (with or without symptoms). Hence, there is much lower chance of false-negative detection results and the assay will be more accurate.

For more information, we welcome you to visit our exhibition booth S1.K72 of the Arab Health 2022 at Dubai World Trade Centre.

Pluslife Mini dock covid test